CAPMATINIB (INC280) IN MET Delta EX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY

Rebecca S. Heist, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B. Garon, Harry J. M. Groen, Daniel S. W. Tan, Toyoaki Hida, Maja de Jonge, Sergey V. Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Monica Giovannini, Juergen Wolf

    OnderzoeksoutputAcademic

    Originele taal-2English
    Pagina's (van-tot)56
    Aantal pagina's1
    TijdschriftNeuro-Oncology
    Volume21
    StatusPublished - nov.-2019
    Evenement24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS - Phoenix, Azerbaijan
    Duur: 20-nov.-201924-nov.-2019

    Citeer dit